Michael Oellerich

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Liver

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bramlage Carsten Paul; Schlumbohm Christina; Pryce Christopher Robert; Mirza Serkan; Schnell Christian; Amann Kerstin; Amstrong Victor William; Eitner Frank; Zapf Antonia; Feldon Joram; Oellerich Michael; Fuchs Eberhard; Müller Gerhard Anton; Strutz Frank
Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkey.
Asif Abdul R; Oellerich Michael; Armstrong Victor William; Hecker Markus; Cattaruzza Marco
T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis.
Beckebaum Susanne; Armstrong Victor W; Cicinnati Vito Rosario; Streit Frank; Klein Christian Georg; Gerken Guido; Paul Andreas; Oellerich Michael
Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Oellerich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bramlage Carsten Paul; Schlumbohm Christina; Pryce Christopher Robert; Mirza Serkan; Schnell Christian; Amann Kerstin; Amstrong Victor William; Eitner Frank; Zapf Antonia; Feldon Joram; Oellerich Michael; Fuchs Eberhard; Müller Gerhard Anton; Strutz Frank
Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkey.
Hypertension 2009;54(5):1115-22.
2009: Asif Abdul R; Oellerich Michael; Armstrong Victor William; Hecker Markus; Cattaruzza Marco
T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis.
Journal of proteome research 2009;8(6):3161-8.
2009: Beckebaum Susanne; Armstrong Victor W; Cicinnati Vito Rosario; Streit Frank; Klein Christian Georg; Gerken Guido; Paul Andreas; Oellerich Michael
Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Therapeutic drug monitoring 2009;31(2):205-10.
2009: Heller Tanja; Asif Abdul R; Petrova Darinka Todorova; Doncheva Yuliana; Wieland E; Oellerich Michael; Shipkova Maria; Armstrong Victor William
Differential proteomic analysis of lymphocytes treated with mycophenolic acid reveals caspase 3-induced cleavage of rho GDP dissociation inhibitor 2.
Therapeutic drug monitoring 2009;31(2):211-7.
2009: van Gelder Teun; Domke Ingrid; Engelmayer Jutta; de Fijter Hans; Kuypers Dirk; Budde Klemens; Koeger Robin; Luthe Hilmar; Oellerich Michael
Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method.
Therapeutic drug monitoring 2009;31(2):218-23.
2009: Wallemacq Pierre; Armstrong Victor W; Brunet Merce; Haufroid Vincent; Holt David W; Johnston Atholl; Kuypers Dirk; Le Meur Yannick; Marquet Pierre; Oellerich Michael; Thervet Eric; Toenshoff Burkhand; Undre Nas; Weber Lutz T; Westley Ian S; Mourad Michel
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Therapeutic drug monitoring 2009;31(2):139-52.
2009: Petrova Darinka T; Heller Tanja; Hitt Reiner; Wieland Eberhard; Oellerich Michael; Armstrong Victor W; Shipkova Maria
Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.
Therapeutic drug monitoring 2009;31(1):31-41.
2009: Brandhorst Gunnar; Luthe Hilmar; Domke Ingrid; Knoke Christiane; Rhode Karl-Heinz; Sauter Heike; Oellerich Michael
Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(7):854-9.
2009: Atanasova S; Wieland E; Schlumbohm C; Korecka M; Shaw L; von Ahsen N; Fuchs E; Oellerich M; Armstrong V
Prenatal dexamethasone exposure in the common marmoset monkey enhances gene expression of antioxidant enzymes in the aorta of adult offspring.
Stress (Amsterdam, Netherlands) 2009;12(3):215-24.
2008: van Gelder Teun; Silva Helio Tedesco; de Fijter Johan W; Budde Klemens; Kuypers Dirk; Tyden Gunnar; Lohmus Aleksander; Sommerer Claudia; Hartmann Anders; Le Meur Yann; Oellerich Michael; Holt David W; Tönshoff Burkhard; Keown Paul; Campbell Scott; Mamelok Richard D
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.
Transplantation 2008;86(8):1043-51.
2008: Weber Lutz T; Hoecker Britta; Armstrong Victor W; Oellerich Michael; Tönshoff Burkhard
Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.
Therapeutic drug monitoring 2008;30(5):570-5.
2008: Petrova Darinka Todorova; Asif Abdul R; Armstrong Victor W; Dimova Ivanka; Toshev Svetoslav; Yaramov Nikolay; Oellerich Michael; Toncheva Draga
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.
Clinical biochemistry 2008;41(14-15):1224-36.
2008: Brandhorst Gunnar; Marquet Pierre; Shaw Leslie M; Liebisch Gerhard; Schmitz Gerd; Coffing Mary Jane; Domke Ingrid; Streit Frank; Luthe Hilmar; Oellerich Michael
Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.
Therapeutic drug monitoring 2008;30(4):428-33.
2008: van Agteren Madelon; Armstrong Victor W; van Schaik Ron H N; de Fijter Hans; Hartmann Anders; Zeier Martin; Budde Klemens; Kuypers Dirk; Pisarski Przemyslav; Le Meur Yann; van der Werf Marloes; Mamelok Richard D; Oellerich Michael; van Gelder Teun
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
Therapeutic drug monitoring 2008;30(4):439-44.
2008: Heller Tanja; Geide Anna; Bonitz Ulrike; Wegner Ulrike; Gröne Hermann-Josef; Armstrong Victor W; Oellerich Michael
Effect of the antioxidant idebenone on adverse events under mycophenolate mofetil therapy in a rat model.
Transplantation 2008;85(5):739-47.
2008: Petrova Darinka Todorova; Nedeva Petya; Maslyankov Svilen; Toshev Svetoslav; Yaramov Nikolay; Atanasova Srebrena; Toncheva Draga; Oellerich Michael; von Ahsen Nicolas
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.
Journal of cancer research and clinical oncology 2008;134(3):317-22.
2008: Brandhorst Gunnar; Tenderich Gero; Zittermann Armin; Oezpeker Cenk; Koerfer Reiner; Oellerich Michael; Armstrong Victor William
Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
Therapeutic drug monitoring 2008;30(1):113-6.
2008: von Ahsen Nicolas; Oellerich Michael; Armstrong Victor W
Characterization of the inosine triphosphatase (ITPA) gene: haplotype structure, haplotype-phenotype correlation and promoter function.
Therapeutic drug monitoring 2008;30(1):16-22.
2007: Petrova Darinka Todorova; Yaramov Nikolay; Toshev Svetoslav; Nedeva Petya; Maslyankov Svilen; von Ahsen Nicolas; Oellerich Michael; Toncheva Draga
Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls.
Onkologie 2007;30(11):559-63.
2007: Dresing Klaus; Armstrong Victor William; Leip Casper-Lennart; Streit Frank; Burchardi Hilmar; Stürmer Klaus-Michael; Oellerich Michael
Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma.
Clinical biochemistry 2007;40(16-17):1194-200.
2007: Dihazi Hassan; Müller Gerhard A; Lindner Sandra; Meyer Markus; Asif Abdul R; Oellerich Michael; Strutz Frank
Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.
Clinical chemistry 2007;53(9):1636-45.
2007: Davies Neal M; Grinyó Josep; Heading Robert; Maes Bart; Meier-Kriesche Herwig-Ulf; Oellerich Michael
Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(9):2440-8.
2007: Wolff Natascha A; Burckhardt Birgitta C; Burckhardt Gerhard; Oellerich Michael; Armstrong Victor W
Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(9):2497-503.
2007: von Ahsen Nicolas; Oellerich Michael
Chip-based genotyping: translation of pharmacogenetic research to clinical practice.
Clinical chemistry 2007;53(7):1186-7.
2007: Heller T; van Gelder T; Budde K; de Fijter J W; Kuypers D; Arns W; Schmidt J; Rostaing L; Powis S H; Claesson K; Macphee I A M; Pohanka E; Engelmayer J; Brandhorst G; Oellerich M; Armstrong V W
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(7):1822-31.
2007: Reinshagen Max; Schütz Ekkehard; Armstrong Victor W; Behrens Christoph; von Tirpitz Christian; Stallmach Andreas; Herfarth Hans; Stein Jürgen; Bias Peter; Adler Guido; Shipkova Maria; Kruis Wolfgang; Oellerich Michael; von Ahsen Nicolas
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Clinical chemistry 2007;53(7):1306-14.
2007: van Hest Reinier M; Doorduijn Jeanette K; de Winter Brenda C M; Cornelissen Jan J; Vulto Arnold G; Oellerich Michael; Löwenberg Bob; Mathot Ron A A; Armstrong Victor William; van Gelder Teun
Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.
Therapeutic drug monitoring 2007;29(3):353-60.
2007: Asif Abdul R; Armstrong Victor W; Voland Antje; Wieland Eberhard; Oellerich Michael; Shipkova Maria
Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats.
Biochimie 2007;89(3):393-402.
2007: Atanasova Srebrena; Shipkova Maria; Svinarov Dobrin; Mladenova Antoaneta; Genova Mariana; Wieland Eberhard; Oellerich Michael; von Ahsen Nicolas
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
Therapeutic drug monitoring 2007;29(1):6-10.
2006: Oellerich Michael; Armstrong Victor W
The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.
Therapeutic drug monitoring 2006;28(6):720-5.
2006: Koehler S C; Von Ahsen N; Schlumbohm C; Asif A R; Goedtel-Armbrust U; Oellerich M; Wojnowski L; Armstrong V W
Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoter.
Xenobiotica; the fate of foreign compounds in biological systems 2006;36(12):1210-26.
2006: Naesens Maarten; Kuypers Dirk R J; Streit Frank; Armstrong Victor W; Oellerich Michael; Verbeke Kristin; Vanrenterghem Yves
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
Clinical pharmacology and therapeutics 2006;80(5):509-21.
2006: Heller Tanja; Kirchheiner Julia; Armstrong Victor W; Luthe Hilmar; Tzvetkov Mladen; Brockmöller Jürgen; Oellerich Michael
AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping.
Therapeutic drug monitoring 2006;28(5):673-7.
2006: Weber Lutz T; Hoecker Britta; Armstrong Victor W; Oellerich Michael; Tönshoff Burkhard
Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Therapeutic drug monitoring 2006;28(5):623-31.
2006: Brandhorst Gunnar; Streit Frank; Goetze Sandra; Oellerich Michael; Armstrong Victor William
Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.
Clinical chemistry 2006;52(10):1962-4.
2006: Atanasova Srebrena; von Ahsen Nicolas; Schlumbohm Christina; Wieland Eberhard; Oellerich Michael; Armstrong Victor
Marmoset glutathione peroxidases: cDNA sequences, molecular evolution, and gene expression.
Journal of medical primatology 2006;35(3):155-64.
2006: van Gelder Teun; Le Meur Yann; Shaw Leslie M; Oellerich Michael; DeNofrio David; Holt Curtis; Holt David W; Kaplan Bruce; Kuypers Dirk; Meiser Bruno; Toenshoff Burkhard; Mamelok Richard D
Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
Therapeutic drug monitoring 2006;28(2):145-54.
2006: Asif Abdul R; Oellerich Michael; Amstrong Victor W; Riemenschneider Birgit; Monod Michel; Reichard Utz
Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens.
Journal of proteome research 2006;5(4):954-62.
2006: Birnbaum Florian; Reis Alexander; Böhringer Daniel; Sokolowska Yevgenia; Mayer Klaus; Voiculescu Adina; Oellerich Michael; Sundmacher Rainer; Reinhard Thomas
An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty.
Transplantation 2006;81(5):767-72.
2006: Oellerich Michael; Barten Markus J; Armstrong Victor W
Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics.
Therapeutic drug monitoring 2006;28(1):35-8.
2006: Shipkova Maria; Lorenz Kristin; Oellerich Michael; Wieland Eberhard; von Ahsen Nicolas
Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.
Clinical chemistry 2006;52(2):240-7.
2005: von Ahsen Nicolas; Armstrong Victor W; Behrens Christoph; von Tirpitz Christian; Stallmach Andreas; Herfarth Hans; Stein Jürgen; Bias Peter; Adler Guido; Shipkova Maria; Oellerich Michael; Kruis Wolfgang; Reinshagen Max; Schütz Ekkehard
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
Clinical chemistry 2005;51(12):2282-8.
2005: Shipkova Maria; Armstrong Victor William; Oellerich Michael; Wieland Eberhard
Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.
Expert opinion on drug metabolism & toxicology 2005;1(3):505-26.
2005: Kamdem Landry K; Streit Frank; Zanger Ulrich M; Brockmöller Jürgen; Oellerich Michael; Armstrong Victor W; Wojnowski Leszek
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.
Clinical chemistry 2005;51(8):1374-81.
2005: Armstrong Victor William; Tenderich Gero; Shipkova Maria; Parsa Amin; Koerfer Reiner; Schröder Heike; Oellerich Michael
Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients.
Therapeutic drug monitoring 2005;27(3):315-21.
2005: El Desoky Ehab S; AbdelSalam Yasser M; Salama Ragaa H; El Akkad Magdy A; Atanasova Srebrena; von Ahsen Nicolas; Armstrong Victor W; Oellerich Michael
NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer in Egyptians.
Therapeutic drug monitoring 2005;27(3):297-304.
2005: Meier-Kriesche Herwig-Ulf; Davies Neal M; Grinyó Josep; Heading Robert; Mamelok Richard; Wijngaard Peter; Oellerich Michael; Maes Bart
Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(5):1164; author reply 1165-6.
2005: Barten Markus J; Shipkova Maria; Bartsch Peter; Dhein Stefan; Streit Frank; Tarnok Attila; Armstrong Victor W; Mohr Friederich W; Oellerich Michael; Gummert Jan F
Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
Therapeutic drug monitoring 2005;27(2):123-31.
2005: Atanasova Srebrena Y; von Ahsen Nicolas; Toncheva Draga I; Dimitrov Tzvetan G; Oellerich Michael; Armstrong Victor W
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN).
Clinical biochemistry 2005;38(3):223-8.
2005: Horowitz Gary L; Zaman Zahur; Blanckaert Norbert J C; Chan Daniel W; Dubois Jeffrey A; Golaz Olivier; Mensi Noury; Keller Franz; Stolz Herbert; Klingler Karl; Marocchi Alessandro; Prencipe Lorenzo; McLawhon Ronald W; Nilsen Olaug L; Oellerich Michael; Luthe Hilmar; Orsonneau Jean-Luc; Richeux Gérard; Recio Fernando; Roldan Esther; Rymo Lars; Wicktorsson Anne-Charlotte; Welch Shirley L; Wieland Heinrich; Grawitz Andrea Busse; Mitsumaki Hiroshi; McGovern Margaret; Ng Katherine; Stockmann Wolfgang
MODULAR ANALYTICS: A New Approach to Automation in the Clinical Laboratory.
Journal of automated methods & management in chemistry 2005;2005():8-25.
2004: Zerr Inga; Bodemer Monika; Kaboth Ulrich; Kretzschmar Hans; Oellerich Michael; Armstrong Victor W
Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease.
Neuroscience letters 2004;371(2-3):163-6.
2004: Heller Tanja; Oellerich Michael; Armstrong Victor William; von Ahsen Nicolas
Rapid detection of ITPA 94C>A and IVS2 + 21A>C gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 + 21A>C polymorphism on splicing efficiency.
Clinical chemistry 2004;50(11):2182-4.
2004: Shipkova Maria; Spielbauer Bettina; Voland Antje; Gröne Hermann-Josef; Armstrong Victor W; Oellerich Michael; Wieland Eberhard
cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy.
Transplantation 2004;78(8):1145-52.
2004: Shipkova Maria; Beck Hermann; Voland Antje; Armstrong Victor W; Gröne Hermann-Josef; Oellerich Michael; Wieland Eberhard
Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue.
Proteomics 2004;4(9):2728-38.
2004: von Ahsen Nicolas; Armstrong Victor W; Oellerich Michael
Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C.
Clinical chemistry 2004;50(9):1528-34.
2004: Kenkel Jeffrey M; Lipschitz Avron H; Shepherd Greene; Armstrong Victor W; Streit Frank; Oellerich Michael; Luby Maureen; Rohrich Rod J; Brown Spencer A
Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: a microdialysis study.
Plastic and reconstructive surgery 2004;114(2):516-24; discussion 525-6.
2004: Weber Lutz T; Armstrong Victor W; Shipkova Maria; Feneberg Reinhard; Wiesel Manfred; Mehls Otto; Zimmerhackl Lothar B; Oellerich Michael; Tönshoff Burkhard;
Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
Therapeutic drug monitoring 2004;26(4):415-24.
2004: Johnston Atholl; Belitsky Philip; Frei Ulrich; Horvath John; Hoyer Peter; Helderman J Harold; Oellerich Michael; Pollard Stephen; Riad Hany; Rigotti Paolo; Keown Paul; Nashan Björn
Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.
European journal of clinical pharmacology 2004;60(6):389-95.
2004: Braun J P; Schroeder T; Buehner S; Dohmen P; Moshirzadeh M; Grosse J; Streit F; Schlaefke A; Armstrong V W; Oellerich M; Lochs H; Konertz W; Kox W J; Spies C
Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass.
Acta anaesthesiologica Scandinavica 2004;48(6):697-703.
2004: Oellerich Michael; Armstrong Victor W; Streit Frank; Weber Lutz; Tönshoff Burkhard
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Clinical biochemistry 2004;37(6):424-8.
2004: Toncheva Draga I; Von Ahsen Nicolas; Atanasova Srebrena Y; Dimitrov Tzvetan G; Armstrong Victor W; Oellerich Michael
Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
Journal of nephrology 2004;17(3):384-9.
2004: Armstrong Victor W; Shipkova Maria; von Ahsen Nicolas; Oellerich Michael
Analytic aspects of monitoring therapy with thiopurine medications.
Therapeutic drug monitoring 2004;26(2):220-6.
2004: Barten Markus J; Streit Frank; Boeger Martin; Dhein Stefan; Tarnok Attila; Shipkova Maria; Armstrong Victor W; Mohr Friedrich W; Oellerich Michael; Gummert Jan F
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
Transplantation 2004;77(8):1154-62.
2004: Hein Ortrud Vargas; Ohring Renate; Schilling Andreas; Oellerich Michael; Armstrong Victor W; Kox Wolfgang J; Spies Claudia
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report.
Critical care (London, England) 2004;8(2):R66-71.
2004: Igonin Anton A; Armstrong Victor W; Shipkova Maria; Lazareva Natalya B; Kukes Vladimir G; Oellerich Michael
Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia.
Clinical biochemistry 2004;37(3):204-9.
2004: Shipkova Maria; Niedmann Paul Dieter; Armstrong Victor W; Oellerich Michael; Wieland Eberhard
Determination of thiopurine methyltransferase activity in isolated human erythrocytes does not reflect putative in vivo enzyme inhibition by sulfasalazine.
Clinical chemistry 2004;50(2):438-41.
2004: Streit Frank; Shipkova Maria; Armstrong Victor William; Oellerich Michael
Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid.
Clinical chemistry 2004;50(1):152-9.
2004: von Ahsen Nicolas; Oellerich Michael
The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system.
Blood 2004;103(2):586-93.
2004: Atanasova S; von Ahsen N; Dimitrov T; Armstrong V; Oellerich M; Toncheva D
MDR1 haplotypes modify BEN disease risk: a study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls.
Nephron. Experimental nephrology 2004;96(1):e7-13.
2003: Dresing K; Pouwels C; Bonsack S; Oellerich M; Schwörer H; Uy A; Stürmer K M
[HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2003;74(11):1026-33.
2003: Indjova Dessislava; Shipkova Maria; Atanasova Srebrena; Niedmann Paul Dieter; Armstrong Victor W; Svinarov Dobrin; Oellerich Michael
Determination of thiopurine methyltransferase phenotype in isolated human erythrocytes using a new simple nonradioactive HPLC method.
Therapeutic drug monitoring 2003;25(5):637-44.
2003: Indjova Dessislava; Atanasova Srebrena; Shipkova Maria; Armstrong Victor W; Oellerich Michael; Svinarov Dobrin
Phenotypic and genotypic analysis of thiopurine s-methyltransferase polymorphism in the bulgarian population.
Therapeutic drug monitoring 2003;25(5):631-6.
2003: Weber L T; Shipkova M; Armstrong V W; Mehls O; Oellerich M; Tönshoff B;
C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients.
Transplantation proceedings 2003;35(6):2128-30.
2003: Johnston Atholl; Chusney Gary; Schütz Ekkehard; Oellerich Michael; Lee Terry D; Holt David W
Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2).
Therapeutic drug monitoring 2003;25(2):167-73.
2003: Maes Bart D; Dalle Ignace; Geboes Karen; Oellerich Michael; Armstrong Victor W; Evenepoel Pieter; Geypens Benny; Kuypers Dirk; Shipkova Maria; Geboes Karel; Vanrenterghem Yves F Ch
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Transplantation 2003;75(5):665-72.
2003: Shipkova Maria; Armstrong Victor William; Wieland Eberhard; Oellerich Michael
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods.
Clinical chemistry 2003;49(2):260-8.
2003: Shipkova Maria; Armstrong Victor William; Oellerich Michael; Wieland Eberhard
Acyl glucuronide drug metabolites: toxicological and analytical implications.
Therapeutic drug monitoring 2003;25(1):1-16.
2002: Braun F; Peters B; Schütz E; Lorf T; Undre N; Oellerich M; Ringe B
Therapeutic drug monitoring of tacrolimus early after liver transplantation.
Transplantation proceedings 2002;34(5):1538-9.
2002: Streit Frank; Armstrong Victor William; Oellerich Michael
Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood.
Clinical chemistry 2002;48(6 Pt 1):955-8.
2002: Wigger Marianne; Armstrong Victor William; Shipkova Maria; Wacke Rainer; Nizze Horst; Streit Frank; von Ahsen Nicolas; Muscheites Jutta; Glasenapp Sabine; Stolpe Hans-Joachim; Oellerich Michael
Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
Therapeutic drug monitoring 2002;24(3):438-43.
2002: Shipkova Maria; Armstrong Victor W; Weber Lutz; Niedmann Paul D; Wieland Eberhard; Haley Jane; Tönshoff Burkhard; Oellerich Michael;
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
Therapeutic drug monitoring 2002;24(3):390-9.
2002: Maes Bart; Oellerich Michael; Ceuppens Jan L; Armstrong Victor W; Evenepoel Pieter; Kuypers Dirk; Messiaen Thierry; Shipkova Maria; Wieland Eberhard; Vanrenterghem Yves
A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(5):923-6.
2002: Weber Lutz T; Shipkova Maria; Armstrong Victor W; Wagner Natalie; Schütz Ekkehard; Mehls Otto; Zimmerhackl Lothar B; Oellerich Michael; Tönshoff Burkhard
Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
Clinical chemistry 2002;48(3):517-25.
2002: Weber Lutz T; Shipkova Maria; Armstrong Victor W; Wagner Natalie; Schütz Ekkehard; Mehls Otto; Zimmerhackl Lothar B; Oellerich Michael; Tönshoff Burkhard
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.
Journal of the American Society of Nephrology : JASN 2002;13(3):759-68.
2002: Oellerich Michael; Armstrong Victor William
Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?
Therapeutic drug monitoring 2002;24(1):40-6.
2001: Shipkova M; Armstrong V W; Kuypers D; Perner F; Fabrizi V; Holzer H; Wieland E; Oellerich M;
Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report.
Therapeutic drug monitoring 2001;23(6):717-21.
2001: Braun F; Kassuhn M; Laabs S; Streit F; Armstrong V W; Oellerich M; Ringe B
Intestinal biotransformation of cyclosporine A in an extracorporeal pig intestine perfusion model.
Transplantation proceedings 2001;33(7-8):3154-5.
2001: Braun F; Armstrong V W; Lorf T; Canelo R; Arndt C; Oellerich M; Ringe B
Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients.
Transplantation proceedings 2001;33(7-8):3108-9.
2001: von Ahsen N; Ehrlich B; Scott C S; Riggert J; Oellerich M
Cryoglobulins interfere with platelet counts by optical and impedance methods but not with the CD61 immunoplatelet count.
Clinical chemistry 2001;47(10):1858-60.
2001: Streit F; Niedmann P D; Shipkova M; Armstrong V W; Oellerich M
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of monoethylglycinexylidide.
Clinical chemistry 2001;47(10):1853-6.
2001: Shipkova M; Armstrong V W; Kiehl M G; Niedmann P D; Schütz E; Oellerich M; Wieland E
Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil.
Clinical chemistry 2001;47(8):1485-8.
2001: von Ahsen N; Richter M; Grupp C; Ringe B; Oellerich M; Armstrong V W
No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.
Clinical chemistry 2001;47(6):1048-52.
2001: Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong V W; Oellerich M; Ringe B
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Transplantation proceedings 2001;33(3):2127-8.
2001: Oellerich M; Armstrong V W
The MEGX test: a tool for the real-time assessment of hepatic function.
Therapeutic drug monitoring 2001;23(2):81-92.
2001: Shipkova M; Strassburg C P; Braun F; Streit F; Gröne H J; Armstrong V W; Tukey R H; Oellerich M; Wieland E
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.
British journal of pharmacology 2001;132(5):1027-34.
2001: Shipkova M; Wieland E; Schütz E; Wiese C; Niedmann P D; Oellerich M; Armstrong V W
The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes.
Transplantation proceedings 2001;33(1-2):1080-1.
2001: Armstrong V W; Shipkova M; Schütz E; Weber L; Tönshoff B; Oellerich M;
Monitoring of mycophenolic acid in pediatric renal transplant recipients.
Transplantation proceedings 2001;33(1-2):1040-3.
2001: Ringe B; Braun F; Schütz E; Füzesi L; Lorf T; Canelo R; Oellerich M; Ramadori G
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
Transplantation 2001;71(4):508-15.
2001: Wieland E; Shipkova M; Schütz E; Braun F; Niedmann P; Armstrong V W; Ringe B; Svinarov D A; Oellerich M
Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liver perfusion model.
Clinical biochemistry 2001;34(1):53-7.
2001: Armstrong V W; Oellerich M
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine.
Clinical biochemistry 2001;34(1):9-16.
2000: von Ahsen N; Oellerich M; Schütz E
DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR.
Clinical chemistry 2000;46(12):1939-45.
2000: Igonin A A; Armstrong V W; Shipkova M; Kukes V G; Oellerich M
The monoethylglycinexylidide (MEGX) test as a marker of hepatic dysfunction in septic patients with pneumonia.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(11):1125-8.
2000: Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
Transplantation proceedings 2000;32(7):2543.
2000: Schütz E; von Ahsen N; Oellerich M
Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design.
Clinical chemistry 2000;46(11):1728-37.
2000: von Ahsen N; Oellerich M; Schütz E
A method for homogeneous color-compensated genotyping of factor V (G1691A) and methylenetetrahydrofolate reductase (C677T) mutations using real-time multiplex fluorescence PCR.
Clinical biochemistry 2000;33(7):535-9.
2000: von Ahsen N; Lewczuk P; Schütz E; Oellerich M; Ehrenreich H
Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation.
Thrombosis research 2000;99(6):549-56.
2000: Wieland E; Oellerich M; Braun F; Schtüz E
c-fos and c-jun mRNA expression in a pig liver model of ischemia/reperfusion: effect of extended cold storage and the antioxidant idebenone.
Clinical biochemistry 2000;33(4):285-90.
2000: Wieland E; Shipkova M; Schellhaas U; Schütz E; Niedmann P D; Armstrong V W; Oellerich M
Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?
Clinical biochemistry 2000;33(2):107-13.
2000: Shipkova M; Schütz E; Armstrong V W; Niedmann P D; Oellerich M; Wieland E
Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
Clinical chemistry 2000;46(3):365-72.
2000: Oellerich M; Shipkova M; Schütz E; Wieland E; Weber L; Tönshoff B; Armstrong V W
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Therapeutic drug monitoring 2000;22(1):20-6.
2000: von Ahsen N; Oellerich M; Schütz E
Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(1)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler.
Clinical chemistry 2000;46(2):156-61.
1999: von Ahsen N; Oellerich M; Armstrong V W; Schütz E
Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler.
Clinical chemistry 1999;45(12):2094-101.
1999: Weber L T; Lamersdorf T; Shipkova M; Niedmann P D; Wiesel M; Zimmerhackl L B; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong V W; Tönshoff B
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Therapeutic drug monitoring 1999;21(5):498-506.
1999: von Ahsen N; Schütz E; Armstrong V W; Oellerich M
Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler.
Clinical chemistry 1999;45(5):694-6.
1999: El Desoky E S; Ahmed A M; Nafeh M A; Ahmed H A; Schütz E; Armstrong V W; Oellerich M
Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis.
Clinical biochemistry 1999;32(3):207-12.
1999: Schütz E; Shipkova M; Armstrong V W; Wieland E; Oellerich M
Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.
Clinical chemistry 1999;45(3):419-22.
1999: Shipkova M; Schütz E; Armstrong V W; Niedmann P D; Wieland E; Oellerich M
Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite.
Transplantation proceedings 1999;31(1-2):1135-7.
1999: Shipkova M; Armstrong V W; Schneider T; Niedmann P D; Schütz E; Wieland E; Oellerich M
Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma.
Clinical chemistry 1999;45(1):127-9.
1999: Weber L T; Schütz E; Lamersdorf T; Shipkova M; Niedmann P D; Oellerich M; Zimmerhackl L B; Staskewitz A; Mehls O; Armstrong V W; Tönshoff B
Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) Therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():34-5.
1999: Weber L T; Schütz E; Lamersdorf T; Shipkova M; Niedmann P D; Oellerich M; Zimmerhackl L B; Staskewitz A; Mehls O; Armstrong V W; Tönshoff B
Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) Therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():33-4.
1998: Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong V W; Oellerich M; Ringe B
How to handle mycophenolate mofetil in combination with tacrolimus?
Transplantation proceedings 1998;30(8):4094-5.
1998: Armstrong V W; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
Clinical chemistry 1998;44(12):2516-23.
1998: Schütz E; Shipkova M; Armstrong V W; Oellerich M
Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans.
Hepatology (Baltimore, Md.) 1998;28(5):1439-40.
1998: Schütz E; Svinarov D; Shipkova M; Niedmann P D; Armstrong V W; Wieland E; Oellerich M
Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Clinical chemistry 1998;44(10):2158-64.
1998: Braun F; Schütz E; Laabs S; Hanack U; Sattler B; Lorf T; Wieland E; Oellerich M; Ringe B
Development of a porcine small bowel ex vivo perfusion model.
Transplantation proceedings 1998;30(6):2613-5.
1998: Weber L T; Shipkova M; Lamersdorf T; Niedmann P D; Wiesel M; Mandelbaum A; Zimmerhackl L B; Schütz E; Mehls O; Oellerich M; Armstrong V W; Tönshoff B
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Journal of the American Society of Nephrology : JASN 1998;9(8):1511-20.
1998: Oellerich M; Armstrong V W; Schütz E; Shaw L M
Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Clinical biochemistry 1998;31(5):309-16.
1998: Shipkova M; Niedmann P D; Armstrong V W; Schütz E; Wieland E; Shaw L M; Oellerich M
Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure.
Clinical chemistry 1998;44(7):1481-8.
1998: Schütz E; Shipkova M; Armstrong V W; Niedmann P D; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
Transplantation proceedings 1998;30(4):1185-7.
1998: Schütz E; Armstrong V W; Shipkova M; Weber L; Niedmann P D; Lammersdorf T; Wiesel M; Mandelbaum A; Zimmerhackl L B; Mehls O; Tönshoff B; Oellerich M
Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients.
Transplantation proceedings 1998;30(4):1182-4.
1998: Schütz E; Shipkova M; Niedmann P D; Wieland E; Armstrong V W; Oellerich M
Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared.
Clinical chemistry 1998;44(6 Pt 1):1269-74.
1998: Binder L; Schiel X; Binder C; Menke C F; Schüttrumpf S; Armstrong V W; Unterhalt M; Erichsen N; Hiddemann W; Oellerich M
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies.
Clinical chemistry 1998;44(2):408-14.
1998: Meyer T; Binder L; Graeber T; Luthe H; Kreuzer H; Oellerich M; Buchwald A B
Superiority of combined CK-MB and troponin I measurements for the early risk stratification of unselected patients presenting with acute chest pain.
Cardiology 1998;90(4):286-94.
1997: Schütz E; Wieland E; Hensel A; Niedmann P D; Dreiss A; Armstrong V W; Schuff-Werner P; Oellerich M
Suppression of leukocyte-enhanced cold ischemia/reperfusion injury of liver endothelium with the benzoquinone antioxidant idebenone.
Clinical biochemistry 1997;30(8):619-24.
1997: Braun F; Schütz E; Christians U; Lorf T; Schiffmann J H; Armstrong V W; Schröter W; Sewing K F; Oellerich M; Ringe B
Pitfalls in monitoring tacrolimus (FK 506).
Therapeutic drug monitoring 1997;19(6):628-31.
1997: Schütz E; Wieland E; Heine L; Hensel A; Schmiedl A; Armstrong V W; Richter J; Schuff-Werner P; Günther E; Oellerich M
Acceleration of hepatocellular energy by idebenone during early reperfusion after cold preservation ameliorates heat shock protein 70 gene expression in a pig liver model.
Transplantation 1997;64(6):901-7.
1997: Andreeva M; Niedmann P D; Schütz E; Wieland E; Armstrong V W; Oellerich M
Determination of MEGX by HPLC with fluorescence detection.
Clinical chemistry 1997;43(6 Pt 1):1081-3.
1997: von Ahsen N; Helmhold M; Schütz E; Eisenhauer T; Armstrong V W; Oellerich M
Cyclosporin A trough levels correlate with serum lipoproteins and apolipoproteins: implications for therapeutic drug monitoring of cyclosporin A.
Therapeutic drug monitoring 1997;19(2):140-5.
1997: Oellerich M; Schütz E; Armstrong V W
Monitoring of cyclosporin and azathioprine in organ transplantation.
Drug metabolism and drug interactions 1997;14(1):17-31.
1996: Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing K F; Armstrong V W; Oellerich M; Ringe B
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Transplantation proceedings 1996;28(6):3175-6.
1996: Heller C; Hinzmann R; Hofmann M; Kaufhold S; Henkel E; Oellerich M
Lipid interference in the determination of the concentration of haemoglobin in plasma using the ACA SX analyzer.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(10):811-6.
1996: Schütz E; Luy-Kaltefleiter M; Kaltefleiter M; Burdelski M; Ringe B; Armstrong V W; Oellerich M
The value of serial determination of MEGX and hyaluronic acid early after orthotopic liver transplantation.
European journal of clinical investigation 1996;26(10):907-16.
1996: von Ahsen N; Helmhold M; Eisenhauer T; Armstrong V W; Oellerich M
Decrease in lipoprotein(a) after renal transplantation is related to the glucocorticoid dose.
European journal of clinical investigation 1996;26(8):668-75.
1996: Schütz E; Gummert J; Mohr F W; Armstrong V W; Oellerich M
Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?
Therapeutic drug monitoring 1996;18(3):228-33.
1996: Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr F W; Dalichau H
Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
The Thoracic and cardiovascular surgeon 1996;44(2):76-80.
1996: Schütz E; Gummert J; Armstrong V W; Mohr F W; Oellerich M
Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(3):199-205.
1995: Oellerich M; Armstrong V W; Kahan B; Shaw L; Holt D W; Yatscoff R; Lindholm A; Halloran P; Gallicano K; Wonigeit K
Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.
Therapeutic drug monitoring 1995;17(6):642-54.
1995: Gummert J F; Schütz E; Oellerich M; Mohr F W; Dalichau H
Monitoring of TPMT in heart transplant recipients under immunosuppressive therapy with azathioprine.
Artificial organs 1995;19(9):918-20.
1995: Wieland E; Schütz E; Armstrong V W; Küthe F; Heller C; Oellerich M
Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions.
Transplantation 1995;60(5):444-51.
1995: Armstrong V W; Schütz E; Kaltefleiter M; Luy M; Helmhold M; Wieland E; Ringe B; Oellerich M
Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period.
European journal of clinical investigation 1995;25(7):485-93.
1995: Lehmann U; Armstrong V W; Schütz E; Regel G; Pape D; Oellerich M
Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure.
Therapeutic drug monitoring 1995;17(2):125-32.
1995: Wieland E; Schütz E; Armstrong V W; Ringe B; Oellerich M
QSA 10 (idebenone) or probucol supplementation of organ preservation solutions prevents oxygen radical-mediated injury of hepatic microsomes.
Transplantation proceedings 1995;27(1):738-40.
1995: Schütz E; Gummert J; Mohr F W; Armstrong V W; Oellerich M
Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation.
Transplantation proceedings 1995;27(1):1298-300.
1995: Armstrong V W; Kaltefleiter M; Luy-Kaltefleiter M; Schütz E; Wieland E; Loss M; Winkler M; Ringe B; Oellerich M
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.
Transplantation proceedings 1995;27(1):1201-3.
1994: Christians U; Kohlhaw K; Esselmann H; Sürig T; Luy M; Kaltefleiter M; Beyrau R; Linck A; Ringe B; Oellerich M
The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients.
Transplantation proceedings 1994;26(5):2827-8.
1994: Oellerich M; Schütz E; Polzien F; Ringe B; Armstrong V W; Hartmann H; Burdelski M
Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors.
Therapeutic drug monitoring 1994;16(3):225-31.
1994: Armstrong V W; Wieland E; Diedrich F; Renner A; Rath W; Kreuzer H; Kuhn W; Oellerich M
Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease.
Lancet 1994;343(8912):1570.
1994: Petersen D; Demertzis S; Freund M; Schumann G; Oellerich M
Individualization of 5-fluorocytosine therapy.
Chemotherapy 1994;40(3):149-56.
1994: Schettler V; Wieland E; Verwiebe R; Schuff-Werner P; Scheler F; Oellerich M
Plasma lipids are not oxidized during hemodialysis.
Nephron 1994;67(1):42-7.
1993: Wieland E; Brandes A; Armstrong V W; Oellerich M
Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(11):725-31.
1993: Ozaki N; Ringe B; Gubernatis G; Takada Y; Yamaguchi T; Yamaoka Y; Oellerich M; Ozawa K; Pichlmayr R
Changes in energy substrates in relation to arterial ketone body ratio after human orthotopic liver transplantation.
Surgery 1993;113(4):403-9.
1993: Oellerich M; Hartmann H; Ringe B; Burdelski M; Lautz H U; Pichlmayr R
Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score.
Transplantation proceedings 1993;25(1 Pt 2):1116-9.
1993: Schütz E; Gummert J; Mohr F; Oellerich M
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.
Lancet 1993;341(8842):436.
1993: Kynast B; Binder L; Marx D; Zoll B; Schmoll H J; Oellerich M; Schauer A
Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients.
Journal of cancer research and clinical oncology 1993;119(5):249-52.
1992: Kohlhaw K; Canello R; Ringe B; Hauss J; Schumann G; Oellerich M; Pichlmayr R
Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation.
Transplantation proceedings 1992;24(6):2699-700.
1992: Wieland E; Schettler V; Diedrich F; Schuff-Werner P; Oellerich M
Determination of lipid hydroperoxides in serum iodometry and high performance liquid chromatography compared.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1992;30(6):363-9.
1992: Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K
Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation.
Clinical chemistry 1992;38(1):123-6.
1992: Ennker I C; Mei M; Nagel E; Hauss J; Reiss G; Oellerich M; Pichlmayr R
[Changes in liver function and morphology after various portocaval bypass operations]
Langenbecks Archiv für Chirurgie 1992;377(3):144-51.
1992: Oellerich M
Therapeutic drug monitoring and pharmacokinetic dose prediction methods.
Wiener klinische Wochenschrift. Supplementum 1992;191():12-5.
1992: Burdelski M; Oellerich M; Düwel J; Raith H; Scheruhn M; Ringe B; Rodeck B; Latta A; Pichlmayr R; Brodehl J
Pre- and post-transplant assessment of liver function in paediatric liver transplantation.
European journal of pediatrics 1992;151 Suppl 1():S39-43.
1991: Oellerich M; Burdelski M; Lautz H U; Binder L; Pichlmayr R
Predictors of one-year pretransplant survival in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1991;14(6):1029-34.
1991: Ozaki N; Gubernatis G; Ringe B; Oellerich M; Washida M; Yamaoka Y; Ozawa K; Pichlmayr R
Arterial blood ketone body ratio as an indicator for viability of donor livers.
Transplantation proceedings 1991;23(5):2487-9.
1991: Oellerich M; Burdelski M; Lautz H U; Rodeck B; Duewel J; Schulz M; Schmidt F W; Brodehl J; Pichlmayr R
Assessment of pretransplant prognosis in patients with cirrhosis.
Transplantation 1991;51(4):801-6.
1991: Oellerich M; Burdelski M; Ringe B; Wittekind C; Lamesch P; Lautz H U; Gubernatis G; Beyrau R; Pichlmayr R
Functional state of the donor liver and early outcome of transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1575-8.
1991: Lautz H U; Oellerich M; Burdelski M; Bürger M; Engelmayer U; Pirlich M; Knoke A; Schmidt F W
Assessment of short-term prognosis in liver transplant candidates with postnecrotic or biliary cirrhosis.
Transplantation proceedings 1991;23(1 Pt 2):1572-4.
1990: Martz W; Oellerich M; Schumann G
Determination of methotrexate in serum: the aca MTHO immunoassay and HPLC compared.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1990;28(12):951-3.
1990: Osaki N; Ringe B; Bunzendahl H; Taki Y; Gubernatis G; Oellerich M; Kuse E R; Burdelski M; Uemoto S; Kimoto M
Postoperative recovery of mitochondrial function of the human liver graft procured and preserved with University of Wisconsin (UW) solution.
Transplant international : official journal of the European Society for Organ Transplantation 1990;3(3):128-32.
1990: Lamesch P; Ringe B; Oellerich M; Burdelski M; Beyrau R; Gubernatis G; Pichlmayr R
Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL tests.
Transplantation proceedings 1990;22(4):1539-41.
1990: Haeckel R; Colic D; Binder L; Oellerich M
Stimulation of glucose metabolism in human blood cells by inhibitors of carnitine-dependent fatty acid transport.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1990;28(5):329-33.
1990: Oellerich M; Burdelski M; Lautz H U; Schulz M; Schmidt F W; Herrmann H
Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
Therapeutic drug monitoring 1990;12(3):219-26.
1990: Beneking M; Oellerich M; Binder L; Choitz G F; Haeckel R
Inhibition of mitochondrial carnitine acylcarnitine translocase by hypoglycaemia-inducing substances.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1990;28(5):323-7.
1989: Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
Lignocaine metabolite formation as a measure of pre-transplant liver function.
Lancet 1989;1(8639):640-2.
1989: Burdelski M; Oellerich M; Bornscheuer A; Luebbe N; Ringe B; Lamesch P; Raude E; Raith H; Scheruhn M; Gubernatis G
Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors.
Transplantation proceedings 1989;21(1 Pt 2):2392-3.
1989: Gubernatis G; Bornscheuer A; Taki Y; Farle M; Lübbe N; Yamaoka Y; Beneking M; Burdelski M; Oellerich M
Total oxygen consumption, ketone body ratio and a special score as early indicators of irreversible liver allograft dysfunction.
Transplantation proceedings 1989;21(1 Pt 2):2279-81.
1988: Binder L; Oellerich M; Haeckel R; Beneking M
Effects of 2-(3-methyl-cinnamyl-hydrazono)-propionate on fatty acid and glucose oxidation in the isolated rat diaphragm using 14C-labelled substrates. Hydrazonopropionic acids, a new class of hypoglycaemic substances, VIII.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1988;26(12):815-9.
1988: Lamesch P; Ringe B; Neuhaus P; Burdelski M; Oellerich M; Pichlmayr R
Qualitative assessment of liver function after hypovolemic, hypoxemic, and ischemic shock in a transplantation model.
Transplantation proceedings 1988;20(5):994-5.
1988: Stein U; Oellerich M; Sybrecht G W; Schneider B
Evaluation of a novel Bayesian method for individualizing theophylline dosage.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1988;26(6):405-14.
1988: Oldhafer K J; Schumann G; Wonigeit K; Oellerich M; Ringe B; Pichlmayr R
Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.
Transplantation proceedings 1988;20(3 Suppl 3):361-5.
1988: Heins M; Kurtin L; Oellerich M; Maes R; Sybrecht G W
Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1988;1(4):306-10.
1988: Böttger H C; Oellerich M; Sybrecht G W
Use of aminoglycosides in critically ill patients: individualization of dosage using Bayesian statistics and pharmacokinetic principles.
Therapeutic drug monitoring 1988;10(3):280-6.
1987: Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt F W; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1987;25(12):845-53.
1987: Burdelski M; Oellerich M; Lamesch P; Raude E; Ringe B; Neuhaus P; Bortfeld S; Kämmerling C; Raith H; Scheruhn M
Evaluation of quantitative liver function tests in liver donors.
Transplantation proceedings 1987;19(5):3838-9.
1987: Beneking M; Oellerich M; Haeckel R; Binder L
Inhibition of mitochondrial carnitine acylcarnitine translocase-mediated uptake of carnitine by 2-(3-methyl-cinnamyl-hydrazono)-propionate. Hydrazonopropionic acids, a new class of hypoglycaemic substances, VI.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1987;25(8):467-71.
1985: Haeckel R; Oellerich M; Schumann G; Beneking M
Hydrazonopropionic acids, a new class of hypoglycemic substances. 5. Inhibition of hepatic gluconeogenesis by 2-(3-methylcinnamyl-hydrazono)-propionate in the rat and guinea pig.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1985;17(3):115-22.
1984: Oellerich M; Haeckel R; Wirries K H; Schumann G; Beneking M
Hydrazonopropionic acids, a new class of hypoglycemic substances. 4. Hypoglycemic effect of 2-(3-methyl-cinnamylhydrazono)-propionate in the rat and guinea pig.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1984;16(12):619-25.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Oellerich

Research Profile (preview)

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Oellerich (preview)

All Publications